
Hepatitis B functional cure with bepirovirsen held in 90% to 92% of responders 48 weeks after stopping all therapy, per data at The Liver Meeting 2026.
Supplements and Featured Publications
Thomas Ciulla, MD, MBA
Chief Medical Officer & Chief Development Officer Clearside Biomedical
Alpharetta, GA
Volunteer Clinical Professor
Indiana University School of Medicine Indianapolis, Indiana
Steven Yeh, MD
Professor of Ophthalmology Truhlsen Eye Institute
University of Nebraska Medical Center Omaha, NE
These faculty have disclosed the following relevant commercial financial relationships or affiliations in the past 12 months.
Thomas Ciulla, MD, MBA
STOCK OWNERSHIP
Clearside Biomedical
EMPLOYMENT
Clearside Biomedical
Steven Yeh, MD
CONSULTANCIES OR PAID ADVISORY BOARDS
Bausch + Lomb, Adverum Biotechnologies, REGENXBIO






